128 related articles for article (PubMed ID: 36031469)
41. Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis.
Oshi M; Margonis GA; Sawada Y; Andreatos N; He J; Kumamoto T; Morioka D; Wolfgang CL; Tanaka K; Weiss MJ; Endo I
Ann Surg Oncol; 2019 Feb; 26(2):593-603. PubMed ID: 30483976
[TBL] [Abstract][Full Text] [Related]
42. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.
Andreou A; Aloia TA; Brouquet A; Dickson PV; Zimmitti G; Maru DM; Kopetz S; Loyer EM; Curley SA; Abdalla EK; Vauthey JN
Ann Surg; 2013 Jun; 257(6):1079-88. PubMed ID: 23426338
[TBL] [Abstract][Full Text] [Related]
43. Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making.
Welsh FK; Tekkis PP; O'Rourke T; John TG; Rees M
Surg Oncol; 2008 Jul; 17(1):3-13. PubMed ID: 18222689
[TBL] [Abstract][Full Text] [Related]
44. Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.
Solaini L; Gardini A; Passardi A; Mirarchi MT; D'Acapito F; La Barba G; Cucchi M; Casadei Gardini A; Frassineti GL; Cucchetti A; Ercolani G
Am Surg; 2019 May; 85(5):488-493. PubMed ID: 31126361
[TBL] [Abstract][Full Text] [Related]
45. Histopathological factors versus margin size in single colorectal liver metastases: Does a 1-cm margin size matter?
Fonseca GM; de Mello ES; Faraj SF; Kruger JAP; Jeismann VB; Coelho FF; Alves VAF; Herman P
Scand J Surg; 2022; 111(1):14574969211069329. PubMed ID: 35188005
[TBL] [Abstract][Full Text] [Related]
46. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases?
Weber JC; Nakano H; Bachellier P; Oussoultzoglou E; Inoue K; Shimura H; Wolf P; Chenard-Neu MP; Jaeck D
Am J Surg; 2001 Jul; 182(1):81-8. PubMed ID: 11532423
[TBL] [Abstract][Full Text] [Related]
47. Conversion therapy with the intent to perform radical local treatment may not be suitable for patients with 10 or more liver metastases from colorectal cancer.
Lin J; Sun H; Zhang W; Hong Z; Lu Z; Pan Z; Hou Z; Peng J
Cancer Med; 2022 Nov; 11(22):4225-4235. PubMed ID: 35466587
[TBL] [Abstract][Full Text] [Related]
48. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
[TBL] [Abstract][Full Text] [Related]
49. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.
Brudvik KW; Mise Y; Chung MH; Chun YS; Kopetz SE; Passot G; Conrad C; Maru DM; Aloia TA; Vauthey JN
Ann Surg Oncol; 2016 Aug; 23(8):2635-43. PubMed ID: 27016292
[TBL] [Abstract][Full Text] [Related]
50. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
Mizuno T; Cloyd JM; Vicente D; Omichi K; Chun YS; Kopetz SE; Maru D; Conrad C; Tzeng CD; Wei SH; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2018 May; 44(5):684-692. PubMed ID: 29551247
[TBL] [Abstract][Full Text] [Related]
51. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
Ayez N; Lalmahomed ZS; Eggermont AM; Ijzermans JN; de Jonge J; van Montfort K; Verhoef C
Ann Surg Oncol; 2012 May; 19(5):1618-27. PubMed ID: 22006375
[TBL] [Abstract][Full Text] [Related]
52. Prediction of Histopathologic Growth Patterns of Colorectal Liver Metastases with a Noninvasive Imaging Method.
Cheng J; Wei J; Tong T; Sheng W; Zhang Y; Han Y; Gu D; Hong N; Ye Y; Tian J; Wang Y
Ann Surg Oncol; 2019 Dec; 26(13):4587-4598. PubMed ID: 31605342
[TBL] [Abstract][Full Text] [Related]
53. A Comprehensive Prognostic Model for Colorectal Cancer Liver Metastasis Recurrence After Neoadjuvant Chemotherapy.
Zhou Z; Han X; Sun D; Liang Z; Wu W; Ju H
Front Oncol; 2022; 12():855915. PubMed ID: 35785215
[TBL] [Abstract][Full Text] [Related]
54. Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - Pushing growth as an independent risk factor for decreased survival.
Falcão D; Alexandrino H; Caetano Oliveira R; Martins J; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Cipriano MA; Castro E Sousa F
Eur J Surg Oncol; 2018 Aug; 44(8):1212-1219. PubMed ID: 29691114
[TBL] [Abstract][Full Text] [Related]
55. Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens.
Truant S; Séquier C; Leteurtre E; Boleslawski E; Elamrani M; Huet G; Duhamel A; Hebbar M; Pruvot FR
HPB (Oxford); 2015 Feb; 17(2):176-84. PubMed ID: 25041611
[TBL] [Abstract][Full Text] [Related]
56. The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas.
Ardito F; Panettieri E; Vellone M; Ferrucci M; Coppola A; Silvestrini N; Arena V; Adducci E; Capelli G; Vecchio FM; Giovannini I; Nuzzo G; Giuliante F
Surgery; 2019 Apr; 165(4):712-720. PubMed ID: 30482518
[TBL] [Abstract][Full Text] [Related]
57. Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status on Overall Survival in Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma.
Endo Y; Sasaki K; Moazzam Z; Lima HA; Alaimo L; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):2023-2032. PubMed ID: 36396868
[TBL] [Abstract][Full Text] [Related]
58. Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study.
Ren X; Li H; Diao M; Xu H; Li L
Int J Clin Oncol; 2020 Apr; 25(4):765-773. PubMed ID: 31701290
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
60. Impact of primary cancer features on behaviour of colorectal liver metastases and survival after hepatectomy.
Cucchetti A; Russolillo N; Johnson P; Tarchi P; Ferrero A; Cucchi M; Serenari M; Ravaioli M; de Manzini N; Cescon M; Ercolani G
BJS Open; 2019 Apr; 3(2):186-194. PubMed ID: 30957066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
